Your browser doesn't support javascript.
loading
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.
Gane, Edward J; Hyland, Robert H; Yang, Yin; Svarovskaia, Evguenia; Stamm, Luisa M; Brainard, Diana M; McHutchison, John G; Stedman, Catherine A M.
Afiliação
  • Gane EJ; Liver Transplant Unit, Auckland City Hospital and University of Auckland, Auckland, New Zealand. Electronic address: edgane@adhb.govt.nz.
  • Hyland RH; Gilead Sciences, Inc, Foster City, California.
  • Yang Y; Gilead Sciences, Inc, Foster City, California.
  • Svarovskaia E; Gilead Sciences, Inc, Foster City, California.
  • Stamm LM; Gilead Sciences, Inc, Foster City, California.
  • Brainard DM; Gilead Sciences, Inc, Foster City, California.
  • McHutchison JG; Gilead Sciences, Inc, Foster City, California.
  • Stedman CAM; Department of Gastroenterology, Christchurch Hospital and University of Otago, Christchurch, New Zealand.
Gastroenterology ; 152(6): 1366-1371, 2017 05.
Article em En | MEDLINE | ID: mdl-28137593
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Benzimidazóis / Hepacivirus / Hepatite C Crônica / Fluorenos / Sofosbuvir Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Benzimidazóis / Hepacivirus / Hepatite C Crônica / Fluorenos / Sofosbuvir Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article